Qianjiang Yongan Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 818.4 million compared to CNY 706.78 million a year ago. Revenue was CNY 826.91 million compared to CNY 712.13 million a year ago.

Net income was CNY 116.59 million compared to CNY 47.23 million a year ago. Basic earnings per share from continuing operations was CNY 0.4 compared to CNY 0.16 a year ago. Diluted earnings per share from continuing operations was CNY 0.4 compared to CNY 0.16 a year ago.